“Proteomics International Laboratories (PIQ) reports its PromarkerD predictive test for diabetic kidney disease has been validated in a major clinical study. The successful trial is another positive step towards Food and Drug Administration (FDA) approval in the U.S.“
Article: Proteomics (ASX:PIQ) validates prognostic diabetes kidney test
